Karyopharm Therapeutics at ASCO 2027

Jun 4–8, 2027 Chicago, IL ~44k attendees Website

Karyopharm Therapeutics at ASCO 2027 in Chicago: Booth 30155.

OrganizationASCO 2027 Attendance
karyopharm.com
Biotech companies
Commercial-stage company marketing the XPO1 inhibitor selinexor (Xpovio) for myeloma and testing it in endometrial cancer and myelofibrosis.
Booth
Exhibiting at Booth 30155

Explore the full ASCO 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Chicago. Leave your work email and we’ll be in touch.

Privacy

Download the full ASCO 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Karyopharm Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction